BlackRock arrives at its May 20 earnings report with the analyst community firmly in its corner — but a significant gap between the Street's optimism and current trading levels makes the print a genuine test of conviction.
Following Q1 results last month, Wall Street moved collectively to lift price targets. Goldman Sachs raised its target to $1,313, Morgan Stanley to $1,393, and UBS to $1,270 — all maintaining positive ratings after a quarter that evidently beat expectations. The mean analyst target of roughly $1,254 implies about 16% upside from the current price of $1,081.90. That gap is the real story. The stock is trading well below where its most bullish backers say it should be, and Wednesday's print is the next opportunity to close it.
The bear case centres on costs. G&A expenses are projected to grow above 13% in 2025, and operating margin estimates have been revised lower — to around 43.9% for 2025 and 45.2% for 2026 — partly reflecting a higher compensation ratio from integrating acquisitions including HPS. JPMorgan sits at the cautious end of the spectrum with a $1,128 target and a Neutral rating, the only major firm not aligned with the broader bullish tilt. For bulls, the counter-argument is simple: BLK generated 6% organic base fee growth last quarter and its $13 trillion-plus AUM base gives it structural pricing power that justifies a premium despite near-term margin compression.
Insider activity adds a layer of nuance. CEO Laurence Fink sold roughly $36 million of stock on April 28, across multiple tranches, with President Rob Kapito selling a further $9 million the day prior. Over the past 90 days, net insider selling totals around $125 million. The trade significance scores are modest — all rated 3 out of 10 — suggesting these are likely routine plan-based disposals rather than a directional view on the upcoming print. Wellington Management is the more constructive signal on the institutional side, having added nearly 968,000 shares in its most recent filing, making it the most aggressive buyer among the top holders.
Options positioning adds a modestly cautious tilt into Wednesday. The put/call ratio has edged up to 1.48, about 1.85 standard deviations above its 20-day average of 1.42 — not extreme by historical standards given the 52-week range runs from 0.87 to 2.07, but directionally leaning defensive. Short interest, at just 1.2% of free float with a borrow rate below 0.4% and ample availability in the lending market, offers no meaningful signal from that angle. The ORTEX short score of 29.9 sits comfortably in the lower half of its range. The earnings report will determine whether the AUM growth story, and the fee rate trajectory that comes with it, can justify the gap between where the stock trades and where its most optimistic backers are targeting.
See the live data behind this article on ORTEX.
Open BLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
